Engineers Gate Manager’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Buy
98,052
+18,200
+23% +$70.1K 0.01% 1621
2026
Q1
$280K Buy
79,852
+41,151
+106% +$169K ﹤0.01% 1736
2025
Q4
$130K Sell
38,701
-63,313
-62% -$164K ﹤0.01% 1878
2025
Q3
$134K Buy
102,014
+28,660
+39% +$29.7K ﹤0.01% 1976
2025
Q2
$52.6K Buy
73,354
+57,720
+369% +$45.3K ﹤0.01% 2044
2025
Q1
$23K Buy
+15,634
New +$37.2K ﹤0.01% 2077
2024
Q3
Sell
-33,046
Closed -$215K 2245
2024
Q2
$215K Sell
33,046
-92,521
-74% -$654K ﹤0.01% 1620
2024
Q1
$1.09M Buy
125,567
+18,029
+17% +$219K 0.03% 776
2023
Q4
$1.23M Buy
+107,538
New +$1.06M 0.04% 686
2023
Q3
Sell
-16,313
Closed -$174K 1937
2023
Q2
$174K Sell
16,313
-64,537
-80% -$694K 0.01% 1500
2023
Q1
$851K Buy
80,850
+54,853
+211% +$614K 0.04% 725
2022
Q4
$322K Sell
25,997
-11,590
-31% -$131K 0.02% 1156
2022
Q3
$389K Buy
37,587
+13,667
+57% +$155K 0.02% 965
2022
Q2
$276K Buy
+23,920
New +$282K 0.01% 1469
2022
Q1
Sell
-103,527
Closed -$1.21M 2075
2021
Q4
$1.21M Buy
+103,527
New +$1.27M 0.05% 513
2021
Q3
Sell
-76,060
Closed -$979K 1800
2021
Q2
$979K Buy
76,060
+54,692
+256% +$626K 0.06% 453
2021
Q1
$239K Sell
21,368
-74,134
-78% -$783K 0.01% 1482
2020
Q4
$1.09M Sell
95,502
-133,703
-58% -$1.46M 0.05% 561
2020
Q3
$2.06M Buy
229,205
+99,342
+76% +$987K 0.1% 290
2020
Q2
$1.34M Buy
+129,863
New +$1.33M 0.07% 463
2020
Q1
Sell
-264,889
Closed -$3.53M 1748
2019
Q4
$3.53M Buy
264,889
+183,508
+225% +$2.02M 0.16% 164
2019
Q3
$699K Buy
+81,381
New +$791K 0.04% 659
2019
Q2
Sell
-268,194
Closed -$3.04M 1257
2019
Q1
$3.04M Buy
268,194
+96,696
+56% +$1.08M 0.18% 170
2018
Q4
$1.49M Buy
171,498
+57,618
+51% +$661K 0.12% 261
2018
Q3
$1.76M Buy
+113,880
New +$1.8M 0.14% 246
2018
Q2
Sell
-133,562
Closed -$1.73M 1064
2018
Q1
$1.73M Buy
+133,562
New +$1.66M 0.12% 319
2016
Q4
Sell
-157,696
Closed -$2.1M 662
2016
Q3
$2.1M Buy
157,696
+59,413
+60% +$695K 0.22% 173
2016
Q2
$1.08M Buy
+98,283
New +$960K 0.08% 412

Other funds holding IRWD

Engineers Gate Manager's IRWD Position: Q2 2026 in Review

Engineers Gate Manager increased its Ironwood Pharmaceuticals (IRWD) stake by 23% in Q2 2026, buying an estimated $70.1K and bringing the position to 98,052 shares worth $413K. The position accounts for 0.01% of the portfolio, ranked #1621.

Engineers Gate Manager first reported a position in IRWD in Q2 2016 and has held it in 28 quarters since. The position peaked at $3.53M in Q4 2019. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Engineers Gate Manager held 98,052 shares of Ironwood Pharmaceuticals worth $413K as of Q2 2026.
  • Engineers Gate Manager bought 18,200 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $70.1K.
  • Ironwood Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1621 holding.
  • Engineers Gate Manager first reported a position in Ironwood Pharmaceuticals in Q2 2016 and has held it in 28 quarters since.
  • Engineers Gate Manager's Ironwood Pharmaceuticals position peaked at $3.53M in Q4 2019.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.